Fastest growing segment fueling the growth of insulin sensitizers market

The global insulin sensitizers market is estimated to be valued at US$ 15.09 Bn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Insulin sensitizers are oral antidiabetic drugs that help manage blood glucose levels in patients with type 2 diabetes by making cells more sensitive to the effects of insulin. They are widely used due to their convenience of oral administration compared to insulin injections.

Market key trends:

One of the key trends in the insulin sensitizers market is the increasing adoption of telehealth and remote patient monitoring. The COVID-19 pandemic has accelerated the shift towards telemedicine as people seek alternatives to in-person visits. Many insulin sensitizer brands are launching digital health programs that enable virtual consultations, remote glucose monitoring, prescription refills, and management of insulin dosages under medical supervision. This is expected to drive the demand for these drugs over the forecast period.

Segment Analysis:

The global insulin sensitizers market is segmented by drug class, drug formulation, and distribution channel. By drug class, the biguanides segment dominated the market in 2022 with a market share of over 35%. Biguanides such as metformin (Glucophage) are front-line therapy for type 2 diabetes due to their effectiveness, low cost, and safety. By drug formulation, the oral segment held the largest share of over 80% in 2022 owing to better patient compliance with oral drugs as compared to injectable drugs. By distribution channel, retail pharmacies accounted for the highest share in 2022 as retail pharmacies are the most accessible channel for patients to obtain prescribed drugs.

Key Takeaways:

The Global Insulin Sensitizers Market Size is expected to reach US$ 22.57 billion by 2030, exhibiting a CAGR of 5.5% over the forecast period owing to the rising prevalence of diabetes across the world.

Regional analysis - North America dominated the market in 2022 and is expected to continue its dominance during the forecast period. This is attributed to the increasing diabetes patient pool and growing obesity rates in the region. Asia Pacific is anticipated to witness the fastest growth during the forecast period.

Key players - Key players operating in the insulin sensitizers market are Eli Lilly and Company, Novo Nordisk, Sanofi, Merck & Co., Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, and Takeda Pharmaceutical. Eli Lilly and Company leads the market with its flagship metformin drug Glucophage.

Comments

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at US$ 2,334.2 Mn in 2024 , and is expected to exhibit a CAGR of 5.2% , in terms of revenue, over the forecast period 2024-2031 to reach US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...

Dive into insights

Search This Blog